Abstract
376P The efficacy and safety of CyberKnife combined with bevacizumab and temozolomide in the treatment of recurrent high-grade glioma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.annonc.2020.08.485
Journal: Annals of Oncology | Publication Date: Sep 1, 2020 |
License type: publisher-specific-oa |
376P The efficacy and safety of CyberKnife combined with bevacizumab and temozolomide in the treatment of recurrent high-grade glioma
Join us for a 30 min session where you can share your feedback and ask us any queries you have